TG-2349, A POTENT PROTEASE INHIBITOR, PLUS PEGIFN/RBV PROVIDES EXCELLENT VIROLOGICAL RESPONSES FOR HARDER-TO-TREAT SUBPOPULATIONS OF HCV-1B NON-CIRRHOTIC PATIENTS
Resource
J. Hepatol., 64, S799-S799
Journal
Journal of Hepatology
Pages
S799
Date Issued
2016
Date
2016
Author(s)
Yu, M. -L.
Hsu, S. -J.
Yeh, C. -T.
Hung, C. -H.
Chen, M. -Y.
Chen, P. -J.
Huang, Y. -H.
Cheng, P. -N.
Chen, C. -M.
Chang, L. -W.
Lin, C. -C.
Sheen, F.
King, C. -H. R.
Kuo, E.
Hsu, M. -C.